Notice for Toripalimab (AA-Med Pty Ltd)
Active ingredients
Toripalimab
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
solution for injection
Indication
For the treatment of nasopharyngeal carcinoma
Therapeutic area
Oncology